Viral Pathogenesis: How Viruses Cause Disease

Introduction to Viral Pathogenesis

Viral pathogenesis is the study of mechanisms by which viruses cause disease in host organisms. Viruses are obligate intracellular parasites that hijack host cell machinery for replication; pathological consequences arise from direct cell damage, immune-mediated injury, and systemic inflammatory responses. The outcome of infection depends on a dynamic interplay between viral virulence factors and host defence mechanisms—including immune competence, genetic background, age, and prior exposure.

Understanding pathogenesis informs vaccine design, antiviral drug development, and clinical management. The same virus may cause mild or fatal disease depending on host factors, explaining why epidemics and pandemics disproportionately affect vulnerable populations. From influenza to HIV, SARS-CoV-2 to Ebola, studying viral pathogenesis bridges molecular biology with clinical medicine.

Entry, Tropism, and Replication

Receptor Binding and Cell Tropism

Viruses initiate infection by binding specific receptors on host cells, a key determinant of tropism—which tissues a virus can infect. Influenza binds sialic acid residues on respiratory epithelium; HIV binds CD4 and chemokine co-receptors CCR5/CXCR4 on T cells and macrophages; SARS-CoV-2 uses ACE2 expressed in lungs, gut, and vascular endothelium. Receptor distribution explains why different viruses cause disease in different organs and why altering receptor expression changes susceptibility. CCR5-delta32 homozygous individuals are highly resistant to HIV infection.

Viral Replication and Host Manipulation

Once inside cells, viruses redirect host biosynthetic machinery to produce viral proteins and nucleic acids. Many viruses encode proteins counteracting antiviral defences: interferon antagonists, anti-apoptotic factors prolonging cell survival during replication, or proteins triggering cell death upon virion release. Herpesviruses establish latency in neurons enabling lifelong persistence with periodic reactivation—herpes simplex recurs throughout life from latent trigeminal ganglia infection. Retroviruses integrate DNA copies permanently into the host genome.

Immune Evasion

Innate Immunity Antagonism

Interferons (IFN-alpha, IFN-beta) are central antiviral cytokines induced by pattern recognition receptor activation sensing viral nucleic acids. Many viruses encode IFN antagonists: influenza NS1 protein sequesters double-stranded RNA; hepatitis C NS3/4A protease cleaves adaptor proteins in innate signalling; SARS-CoV-2 ORF6 blocks nuclear import of interferon-stimulated gene transcription factors. Understanding these mechanisms guides development of broad-spectrum antivirals targeting immune evasion proteins rather than virus-specific targets.

Adaptive Immune Evasion

Viruses evade adaptive immunity through diverse strategies: HIV mutates surface glycoproteins rapidly under antibody pressure, generating quasi-species diversity. Herpesviruses downregulate MHC class I molecules on infected cells, preventing cytotoxic T lymphocyte recognition—NK cells compensate via missing-self detection. Epstein-Barr virus infects B cells directly, exploiting them as a reservoir while expressing minimal latency genes avoiding T cell detection. Measles virus causes transient immune amnesia by depleting immunological memory cells, increasing susceptibility to other infections for months after recovery.

Disease Mechanisms

Viral pathology results from multiple simultaneous mechanisms. Direct cytopathic effect damages infected tissues through cell lysis during replication. Immunopathology from excessive inflammation can exceed direct viral damage—severe COVID-19 reflects cytokine storm rather than direct lung destruction. Autoimmunity triggered by molecular mimicry occurs when viral antigens resemble host proteins. Viral oncogenesis—cancer caused by viruses—affects HPV (cervical cancer), Epstein-Barr virus (lymphomas), and hepatitis B/C (hepatocellular carcinoma). These distinct mechanisms require different therapeutic approaches: antivirals, immunosuppression, or targeted cancer therapy.

Examples and Applications

Example 1: Influenza Pathogenesis

Influenza infects respiratory epithelial cells; viral neuraminidase cleaves sialic acid releasing progeny virions. When cytokine storm drives severe disease, supportive care and antivirals (oseltamivir) reduce morbidity. Annual antigenic drift and pandemic reassortment of haemagglutinin and neuraminidase segments explain why annual vaccination reformulation is needed and why novel pandemic strains cause higher mortality in immunologically naive populations.

Example 2: HIV/AIDS Pathogenesis

HIV infects CD4+ T helper cells via gp120 binding CD4 and co-receptor. Reverse transcriptase copies viral RNA to DNA; integrase inserts this provirus permanently. Gradual CD4 cell depletion over years causes AIDS—opportunistic infections by Pneumocystis jirovecii, Toxoplasma, Cryptococcus. Antiretroviral therapy (ART) suppresses viral replication below detection, preserving immune function and preventing transmission. Three-drug regimens prevent resistance emergence by requiring simultaneous mutations in multiple viral genes.

Example 3: SARS-CoV-2 Lung Pathology

SARS-CoV-2 infects ACE2-expressing type II pneumocytes in alveoli. In severe COVID-19, delayed but dysregulated interferon response with excessive macrophage and neutrophil activation causes diffuse alveolar damage, fibrosis, and respiratory failure. Dexamethasone reduced 28-day mortality in ventilated patients—not as an antiviral but as an immunosuppressant, illustrating how understanding immunopathology guides treatment distinctly from antiviral approaches.

Example 4: Herpes Simplex Latency

HSV-1 establishes lifelong latency in trigeminal sensory ganglia. During latency, only latency-associated transcripts (LATs) are expressed—non-coding RNAs suppressing lytic gene expression and promoting neuronal survival. Stress, UV exposure, or immunosuppression triggers reactivation through incompletely understood mechanisms. Acyclovir—a nucleoside analogue phosphorylated only by viral thymidine kinase—selectively inhibits viral DNA polymerase, treating outbreaks and reducing transmission frequency.

Example 5: HPV and Cervical Cancer

High-risk HPV (types 16, 18) E6 protein degrades tumour suppressor p53; E7 inactivates retinoblastoma protein pRb, removing key cell cycle brakes. Persistent infection leads to cervical intraepithelial neoplasia progressing to invasive cancer over 10-20 years. HPV vaccination with nonavalent vaccine prevents infection with types causing 90% of cervical cancers. Organised cervical screening with Pap smear or HPV testing detects pre-cancerous changes. Combined vaccination and screening could virtually eliminate cervical cancer as a public health problem.

Example 6: Dengue Antibody-Dependent Enhancement

Dengue virus has four antigenically distinct serotypes. Primary infection induces protective immunity to the infecting serotype but cross-reactive antibodies to others. Secondary infection with a different serotype can cause antibody-dependent enhancement (ADE): cross-reactive antibodies faciliate viral entry into Fc receptor-bearing macrophages without neutralising, increasing viral load and triggering severe dengue haemorrhagic fever. ADE complicates dengue vaccine development—a vaccine must provide strong immunity to all four serotypes simultaneously.

Example 7: Rabies Neurotropism

Rabies virus binds nicotinic acetylcholine receptors and p75 neurotrophin receptor at the neuromuscular junction, then travels retrogradely along peripheral nerves to the brain—slowly (1-3 cm/day), explaining prolonged incubation period (weeks to months). Once it reaches the brain, rapid spread causes encephalitis. Post-exposure prophylaxis (vaccine + immunoglobulin) is nearly 100% effective if given before symptoms begin; once cerebellar symptoms appear, rabies is virtually uniformly fatal. Understanding neurotropic spread guided development of effective post-exposure protocols.

Example 8: Poliovirus Neuropathology

Poliovirus infects the gut via CD155 receptor; viraemia allows CNS spread. In the spinal cord, virus destroys anterior horn motor neurons causing flaccid paralysis in under 1% of infections—most are asymptomatic. Oral and inactivated polio vaccines have nearly eradicated the disease globally. Post-polio syndrome—fatigue and weakness decades later—reflects overuse of surviving neurons compensating for those destroyed. Wild poliovirus type 2 and 3 have been eradicated; type 1 remains endemic in very few countries.

Try it live

Everything above runs in your browser — open Viral Infection Cycle and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.